期刊文献+

促红细胞生成素对大鼠骨髓间充质干细胞增殖和细胞周期的影响 被引量:6

Effects of erythropoietin on proliferation and cell circle stage of rat bone marrow mesenchymal stem cells in vitro
下载PDF
导出
摘要 目的:观察促红细胞生成素(eryrthropoietin,EP)对大鼠骨髓间充质干细胞(mesenchymalstemcells,MSCs)增殖和细胞周期的影响。方法:无血清条件下,不同剂量(0,0.25,0.5,1,2,10U/ml)EP与MSCs共培养24h,MTT方法检测MSC增殖情况;10U/mlEP与MSCs共培养72h后,流式细胞仪检测细胞周期情况。结果:MTT结果表明,EP呈剂量依赖性促进MSCs增殖,除0.25U/ml剂量外,其余各组都与对照组有显著性差异,以10U/mlEP促MSCs增殖作用最明显。流式细胞检测表明,EP组能降低G0/G1期比例,增加S期和G2/M期细胞比例,与对照组相比,差异均有显著性意义(P<0.05)。结论:EP可以促进骨髓间充质干细胞增殖,并且这种影响呈剂量依赖性。 Objective:To determine the effect of erythropoietin (EP) on the proliferation of mesenchymal stem cells (MSCs) in vitro. Methods:Under serum free culture media, MSCs were incubated with different doses of EP for 24 h (0, 0.25, 0.5, 1, 2, 10 U/ml), and then the proliferation of MSCs was measured by MTT assay. Cell circle stage was measured by flow cytometry assays after incubation of 10 U/ml EP for 72 h. Results:MTT assay showed that EP could enhance MSCs proliferation in a dose-dependent manner. There was significant difference among EP treatment groups and control group,except 0.25 U/ml group. The effects on the proliferation of MSCs was highest in 10 U/ml group. Furthermore,flow cytometry (FCM) assays showed that, compared with control group, EP could significantly decrease G0/G1 ratio, and increase S stage and G2/M stage ratio. Conclusion:EP could enhance MSCs proliferation in dose-dependent manner.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第2期142-144,162,F0003,共5页 Journal of Nanjing Medical University(Natural Sciences)
关键词 促红细胞生成素 骨髓间充质干细胞 增殖 细胞周期 erythropoietin mesenchymal stem cells proliferation cell circle stage
  • 相关文献

参考文献4

二级参考文献33

  • 1Biancl P, Robey PG. Stem cells in tissue engineering. Nature,2001,414:118-121.
  • 2Tomita S, Mickle DA, Weisel RD,et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg, 2002, 123:1132-1140.
  • 3Wang JS, Dominique ST, Galipeau J,et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000,120: 999-1006.
  • 4Strauer BE, Brehm M, Zeus T, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction . Dtsch Med Wochenschr, 2001 ,126:932-938.
  • 5Olivette G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodelling after myocardial infarction in rats. Cir Res, 1991, 68:856-869.
  • 6Yau TM, Tomita S, Weisel RD, et al. Beneficial effect of auologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg, 2003, 75:169-176.
  • 7Sun J, Yu XL. Teaching materials for experiment Zoology , Beijing supervising office of experiment animal.1999,16-20.孙靖,遇秀玲.编&lt;实验动物学讲义&gt;.北京市实验动物从业人员上岗培训教材(试行).北京市实验动物管理办公室,
  • 8McIntosh K, Bartholomew A. Stromal cell modulation of the immune system. A potential role for mesenchymal stem cells. Graft, 2000, 3:324-328.
  • 9Bittira B, Kuang JQ, Abdulaziz AK,et al. In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann Thorac Surg, 2002, 74:1154-1160.
  • 10Pittengen MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J].Science, 1999, 284:143 - 147.

共引文献45

同被引文献141

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部